Blood tests to guide treatment for recurrent cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at whether simple blood tests can help predict how well first-line treatment works for cervical cancer that has come back or spread. It aims to improve future care by tracking changes in the blood over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cervical cancer confirmed by biopsy (types: squamous cell, adenocarcinoma, or adenosquamous).
- Your cancer has come back or spread, including stage IVB at first diagnosis.
- You have completed first-line treatment with chemo plus an immunotherapy drug, with or without bevacizumab, and the cancer fully disappeared (complete response).
- You have had a biopsy of the recurrent or metastatic area before treatment, and that sample is available at the study hospital.
- You were part of a clinical trial for first-line treatment at this hospital, and you are willing to participate in this study.
- You must be at least 18 years old, willing to give blood samples at scheduled times, and attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special blood test to look for tumor DNA in your blood to monitor for cervical cancer recurrence and help guide treatment decisions. It may help your doctor know if your cancer is coming back and choose the best treatment options.
This trial tests a combination of three drugs—camrelizumab (an immunotherapy that helps your immune system fight cancer), famitinib (a targeted therapy that blocks blood vessel growth to tumors), and standard chemotherapy—for cervical cancer that has come back or spread and cannot be removed with surgery or radiation. The goal is to see if this combination is safe and effective.
This study tests whether a blood test can find cancer returning earlier than usual scans, in people who had endometrial or cervical cancer. If you've finished or are on standard treatment, your blood may help show if the cancer comes back sooner.
This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.
This study tests whether DNA found in blood and urine can help detect cervical cancer and monitor it after treatment. If you’re newly diagnosed, these minimally invasive samples may help doctors follow your disease more easily over time.
This study uses a simple blood test to look for tiny bits of cancer DNA after your treatment. It aims to see if this test can help predict whether the cancer might come back.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.